Aiforia lands EU financing to develop AI-powered cancer detection
recent articles
EIB provides €20 million venture debt financing to Finnish life-science company Aiforia, to further develop its AI powered platform used in digital tissue analysis. Supported under the European Commission’s InvestEU programme, the...
Albuquerque, NM, July 30, 2026 – Indica Labs today announces the launch of the ADC Target Scoring module for the HALO® image analysis platform, a powerful new functionality that supports the development of next-generation precision...
The latest from the Indica Labs Blog Automated biomarker scoring for breast cancer pathology just got smarter. The latest HALO Breast IHC AI release introduces new features designed to remove the remaining manual steps from...
Albuquerque, NM, July 28, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced new intelligent tissue classification capabilities for HALO Breast IHC AI, its AI-powered breast...
From the Lumea blog: We are thrilled to announce that we received a global award for exception achievement from the international awards program The Global Recognition Awards™. We couldn’t be prouder of our team and the countless hours...
Aiforia is helping University Hospital Southampton NHS Foundation Trust support faster, more consistent pathology workflows on Microsoft Azure through AI-assisted lung cancer analysis. For years, the...
